Efficacy and safety of vedolizumab in Crohn’s disease in patients from Asian countries in the GEMINI 2 study.

Autor: Banerjee, Rupa1 banerjee@hotmail.com, Sai Wei Chuah2, Ida Normiha Hilmi3, Deng-Chyang Wu4, Suk-Kyun Yang5, Demuth, Dirk6, Lindner, Dirk7, Adsul, Shashi7
Zdroj: Intestinal Research. Jan2021, Vol. 19 Issue 1, Following p83-100. 18p.
Databáze: Academic Search Ultimate